Phase I Trial of Gemcitabine Dose Escalation with Concurrent Radiotherapy for Patients with Locally Advanced Pancreatic Cancer

Publisher： Karger

E-ISSN： 1424-3911|10|1|60-65

ISSN： 1424-3903

Source： Pancreatology, Vol.10, Iss.1, 2010-03, pp. : 60-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma

By  

CANCER, Vol. 121, Iss. 7, 2015-04 ,pp. : 1128-1137

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II Trial of Primary Radiation Therapy and Concurrent Chemotherapy for Patients with Locally Advanced Pancreatic Cancer

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 493-499

Karger

Access to resources Recommend Favorite

Phase I Dose-Finding Study of Vandetanib in Combination with Gemcitabine in Locally Advanced Unresectable or Metastatic Pancreatic Adenocarcinoma

By  

Oncology, Vol. 81, Iss. 1, 2011-09 ,pp. : 50-54

Karger

Access to resources Recommend Favorite

Mitomycin C, 5-Fluorouracil, Leucovorin, and Oxaliplatin as a Salvage Therapy for Patients with Cisplatin-Resistant Advanced Gastric Cancer: A Phase I Dose Escalation Trial

By  

Oncology Research and Treatment, Vol. 30, Iss. 1-2, 2007-01 ,pp. : 29-34

Karger

Access to resources Recommend Favorite

Cisplatin-Docetaxel Induction plus Concurrent 3-D Conformal Radiotherapy and Weekly Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer Patients: A Phase II Trial

By  

Oncology, Vol. 83, Iss. 6, 2012-09 ,pp. : 321-328

Karger

Access to resources Recommend Favorite